Rapport Therapeutics, Inc. (RAPP) stock

RAPPNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/30

$26.15+0.30 (+1.16%)

Close on Nov 13, 2026Market cap $1.25BP/E –Yield –

Rapport Therapeutics operating margin

Operating margin is operating income as a percentage of revenue.

Change is against the same quarter a year earlier.

Period	Period end	Value	Change (pts)
Q1 FY2026	Mar 31, 2026	-121.1%	–

See a number that looks wrong?